exhibit both a proliferating phase and an involution phase, whereas vascular malformations are more stable and fail to regress Patients and methods: The retrospective study was done on ninety patients with hemangiomas, eighty patients treated with intralesional triamcinolone acetonide injection at age 6 years to 45 years and ten patients who were treated surgically considered as a control group at al-sadder teaching hospital -Al Najaf and department of oral and maxillofacial surgery, Kufa, college of dentistry 2007 to 2014 Results: Examined group eighty patients with hemangiomas were treated with intralesional triamcinolone acetonide injection thirty six cases were male and forty four cases were female. our results revealed that [10-19] years was most common age group with heamangiomas twenty cases and revealed that females were most common than males forty four cases which were complaint heamangiomas Conclusions: The treatment of heamangioma is dependent on stages of growth, primary site, size and depth of heamangioma. Each treatment option has limited therapeutic benefit with its own side-effect profile and risks. There is no gold-standard treatment applicable to all patients